MAPK3 and cancer: In recent years, it has been found that overactivation of the ERK1/2 signaling pathway plays an important role in the occurrence and development of a variety of diseases, including cancer, inflammation, neurodegenerative diseases, diabetes, and cardiovascular diseases.